Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Synthesis of 1,5-Anhydrohexitol Nucleosides as Mimics of AZT, D4T and DDC — Ilse Verheggen (1996) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Synthesis of 1,5-Anhydrohexitol Nucleosides as Mimics of AZT, D4T and DDC
Shared by
De Clercq Erik
KU Leuven
Synthesis of 1,5-Anhydrohexitol Nucleosides as Mimics of AZT, D4T and DDC
Article
1996
en
Authors
+3 more
IV
Ilse Verheggen
AA
Arthur Van Aerschot
JR
Jef Rozenski
Abstract
1 min read
Abstract 1,5-Anhydrohexitol congeners of AZT, D4T and DDC were synthesized. These compounds did not show anti-HIV activity.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1996
ChemInform Abstract: Synthesis of 1,5‐Anhydrohexitol Nucleosides as Mimics of AZT, D4T, and DDC.
Ilse Verheggen
,
Arthur Van Aerschot
,
Jef Rozenski
,
G. Janssen
,
De Clercq Erik
,
Piet Herdewijn
Article
1993
Synthesis and antiherpes virus activity of 1,5-anhydrohexitol nucleosides
Ilse Verheggen
,
Arthur Van Aerschot
,
Suzanne Toppet
,
Robert Snoeck
,
Gerard Janssen
,
Jan Balzarini
,
De Clercq Erik
,
Piet Herdewijn
Article
1997
Synthesis and Antiviral Activity of the α-Analogues of 1,5-Anhydrohexitol Nucleosides (1,5-Anhydro-2,3-dideoxy-<scp>d</scp>-ribohexitol Nucleosides)
Nafizal Hossain
,
Jef Rozenski
,
De Clercq Erik
,
Piet Herdewijn
Article
2004
Chemoenzymatic Syntheses of Homo‐ and Heterodimers of AZT and d4T, and Evaluation of Their Anti‐HIV Activity
Moha Taourirte
,
L. Ait Mohamed
,
A. Rochdi
,
Jean‐Jacques Vasseur
,
Susana Fernández
,
Miguel Ferrero
,
Vicente Gotor
,
Christophe Pannecouque
,
De Clercq Erik
,
Hassan B. Lazrek
Article
1995
Synthesis and Anti-HIV Activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] Dimers as Potential Multifunctional Inhibitors of HIV-1 Reverse Transcriptase
Sonsoles Velázquez
,
Rosa Álvarez
,
Ana San‐Félix
,
M. Luísa Jimeno
,
De Clercq Erik
,
Jan Balzarini
,
Marı́a-José Camarasa
Discussion(0)
No comments yet. Be the first to comment.